Genomic sequence analysis of the United States infectious laryngotracheitis vaccine strains chicken embryo origin (CEO) and tissue culture origin (TCO)

Virology

Volumn 440, Issue 1, 2013, Pages 64-74

  García, Maricarmen ^a   Volkening, Jeremy ^b   Riblet, Sylva ^a   Spatz, Stephen ^c  

^a UNIVERSITY OF GEORGIA   (United States)

^b BASE2BIO   (United States)

^c AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Attenuated; CEO; Gallid herpesvirus1; Infectious laryngotracheitis; Sequencing; TCO; Vaccine; Virulence

Indexed keywords

FOWL LARYNGOTRACHEITIS; FOWL LARYNGOTRACHEITIS VACCINE; GENOMIC DNA; GLYCOPROTEIN B; INFECTIOUS LARYNGOTRACHEITIS VACCINE; LARYNGO VAC; LT BLEN; LT IVAX; THREONINE; THREONINE 644; TRACHIVAX; UNCLASSIFIED DRUG; VACCINE; VIRUS DNA; VIRUS VACCINE;

ANIMAL TISSUE; ARTICLE; CHICKEN; CLADISTICS; CONTROLLED STUDY; DNA SEQUENCE; EMBRYO; GENE FREQUENCY; GENE MUTATION; GENETIC DIFFERENCE; GENOME ANALYSIS; ILTOVIRUS; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE CULTURE; UNITED STATES; VIRUS GENE; VIRUS GENOME; VIRUS ISOLATION; VIRUS STRAIN; VIRUS VIRULENCE;

AMINO ACID SEQUENCE; ANIMALS; CHICK EMBRYO; CHICKENS; DNA, VIRAL; GENE EXPRESSION REGULATION, VIRAL; GENE FREQUENCY; GENOME, VIRAL; GENOTYPE; HERPESVIRIDAE INFECTIONS; ILTOVIRUS; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; SERIAL PASSAGE; TISSUE CULTURE TECHNIQUES; UNITED STATES; VACCINES, ATTENUATED; VIRAL PROTEINS; VIRAL VACCINES;

GALLUS GALLUS;

EID: 84876415391     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.02.007     Document Type: Article

References (80)

1. Andreasen J.R., Glisson J.R., Goodwin M.A., Resurreccion R.S., Villegas P., Brown J. Studies of infectious laryngotracheitis vaccines: immunity in layers. Avian Dis. 1989, 33(3):524-530.
2. Atanasiu D., Saw W.T., Cohen G.H., Eisenberg R.J. Cascade of events governing cell-cell fusion induced by herpes simplex virus glycoproteins gD, gH/gL, and gB. J. Virol. 2010, 84(23):12292-12299.
3. Bagust T.J., Johnson M.A. Avian infectious laryngotracheitis: virus-host interactions in relation to prospects for eradication. Avian. Pathol. 1995, 24(3):373-391.
4. Baines J.D., Roizman B. The open reading frames UL3, UL4, UL10, and UL16 are dispensable for the replication of herpes simplex virus 1 in cell culture. J. Virol. 1991, 65(2):938-944.
5. Beaudette F.R., Hudson C.B. Newly recognized poultry disease. North Am. Vet. 1933, 14:50.
6. Biswas S., Miguel R.N., Sukla S., Field H.J. A mutation in helicase motif IV of herpes simplex virus type 1 UL5 that results in reduced growth in vitro and lower virulence in a murine infection model is related to the predicted helicase structure. J. Gen. Virol. 2009, 90(Pt 8):1937-1942.
7. Biswas S., Tiley L.S., Zimmermann H., Birkmann A., Field H.J. Mutations close to functional motif IV in HSV-1 UL5 helicase that confer resistance to HSV helicase-primase inhibitors, variously affect virus growth rate and pathogenicity. Antiviral Res. 2008, 80(1):81-85.
8. Brandly C.A., Bushnell L.D. A report of some investigations of ILT. Poult. Sci. 1934, 13:212-217.
9. Brandt C.R., Kintner R.L., Pumfery A.M., Visalli R.J., Grau D.R. The herpes simplex virus ribonucleotide reductase is required for ocular virulence. J. Gen. Virol. 1991, 72(Pt 9):2043-2049.
10. Cameron J.M., McDougall I., Marsden H.S., Preston V.G., Ryan D.M., Subak-Sharpe J.H. Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target. J. Gen. Virol. 1988, 69(Pt 10):2607-2612.
11. Chandra Y.G., Lee J., Kong B.W. Genome sequence comparison of two United States live attenuated vaccines of infectious laryngotracheitis virus (ILTV). Virus Genes 2012, 44(3):470-474.
12. Chevreux B., Wetter T., Suhai S. Genome sequence assembly using trace signal and additional sequence information. Comp.Sci. Biol. GCB 1999, 1:45-56.
13. Cochran, M.D., MacDonald, R.D. (1998). Recombinant Herpesvirus of Turkeys and Uses Thereof. Vol. 5,853,733. Syntro Corpoaration, USA.
14. Corpet F. Multiple sequence alignment with hierarchical clustering. Nucleic. Acids Res. 1988, 16(22):10881-10890.
15. Cover M.S., Benton W.J. The biological variation of infectious laryngotracheitis virus. Avian Dis. 1958, 2:375-383.
16. Creelan J.L., Calvert V.M., Graham D.A., McCullough S.J. Rapid detection and characterization from field cases of infectious laryngotracheitis virus by real-time polymerase chain reaction and restriction fragment length polymorphism. Avian Pathol. 2006, 35(2):173-179.
17. Davison A.J., Eberle R., Hayward G.S., McGeoch D.J., Minson A.C., Pellet P.E., Roizman B., Studdert M.J., Thiry E. Family herpesviridae. Virus Taxonomy: Eight Report of the International Committee on Taxonony of Viruses 2005, 193-212. Academic Press, San Diego, CA. C.M. Fauquet, M.A. Mayo, J. Maniloff, U. Desselberger, L.A. Ball (Eds.).
18. Davison S., Dufour-Zavala L., García M., Ghori H., Hoerr F., Hopkins B., Smith J., Waldrip D. Proceedings of the 109th Annual Meeting of the United States Animal Health Association, Hershey, PA 2005, 580-603.
19. Devlin J.M., Browning G.F., Gilkerson J.R. A glycoprotein I- and glycoprotein E-deficient mutant of infectious laryngotracheitis virus exhibits impaired cell-to-cell spread in cultured cells. Arch. Virol. 2006, 151(7):1281-1289.
20. Fuchs W., Mettenleiter T.C. DNA sequence of the UL6 to UL20 genes of infectious laryngotracheitis virus and characterization of the UL10 gene product as a nonglycosylated and nonessential virion protein. J. Gen. Virol. 1999, 80(Pt 8):2173-2182.
21. Fuchs W., Veits J., Helferich D., Granzow H., Teifke J.P., Mettenleiter T.C. Molecular biology of avian infectious laryngotracheitis virus. Vet. Res. 2007, 38(2):261-279.
22. Fulton R.M., L.S.D., Will M. Effect of route of vaccination on the prevention of infectious laryngotracheitis in commercial egg-laying chickens. Avian Dis. 2000, 4:8-16.
23. Gelenczei E., Marty E. Strain stability and immunologic characterizatics of tissue-culture modified infectious laryngotracheitis virus. Avian Dis. 1962, 9:44-56.
24. Goodman J.L., Engel J.P. Altered pathogenesis in herpes simplex virus type 1 infection due to a syncytial mutation mapping to the carboxy terminus of glycoprotein B. J. Virol. 1991, 65(4):1770-1778.
25. Guy J.S., Bagust T.J. Laryngotracheitis. Dis. Poult. 2003, 121-134. Iowa State Press, Ames, IA. 11th Ed. Y.M. Saif, H.J. Barnes, J.R. Glisson, A.M. Fadly, L.R. McDougald, D.E. Swayne (Eds.).
26. Guy J.S., Barnes H.J., Munger L.L., Rose L. Restriction endonuclease analysis of infectious laryngotracheitis viruses: comparison of modified-live vaccine viruses and North Carolina field isolates. Avian Dis. 1989, 33(2):316-323.
27. Guy J.S., Barnes H.J., Smith L. Increased virulence of modified-live infectious laryngotracheitis vaccine virus following bird-to-bird passage. Avian Dis. 1991, 35(2):348-355.
28. Guy J.S., Garcia M. Infectious laryngotracheitis virus. Diseases of Poultry 2008, Wiley-Blackwell, Hoboken, NJ. 12th Ed. Y.M. Saif, J.R. Glisson, A.M. Fadly, L.R. McDougald, L.K. Nolan, D.E. Swayne (Eds.).
29. Han M.G., Kim S.J. Analysis of Korean strains of infectious laryngotracheitis virus by nucleotide sequences and restriction fragment length polymorphism. Vet Microbiol. 2001, 83(4):321-331.
30. Han M.G., Kim S.J. Efficacy of live virus vaccines against infectious laryngotracheitis assessed by polymerase chain reaction-restriction fragment length polymorphism. Avian Dis. 2003, 47(2):261-271.
31. Heineman T.C., Cohen J.I. Deletion of the varicella-zoster virus large subunit of ribonucleotide reductase impairs growth of virus in vitro. J. Virol. 1994, 68(5):3317-3323.
32. Hilbink F.W., Oei H.L., van Roozelaar D.J. Virulence of five live vaccines against avian infectious laryngotracheitis and their immunogenicity and spread after eyedrop or spray application. Vet Q 1987, 9(3):215-225.
33. Hughes C.S., Gaskell R.M., Jones R.C., Bradbury J.M., Jordan F.T. Effects of certain stress factors on the re-excretion of infectious laryngotracheitis virus from latently infected carrier birds. Res. Vet. Sci. 1989, 46(2):274-276.
34. Hutchinson L., Graham F.L., Cai W., Debroy C., Person S., Johnson D.C. Herpes simplex virus (HSV) glycoproteins B and K inhibit cell fusion induced by HSV syncytial mutants. Virology 1993, 196(2):514-531.
35. Kaashoek M.J., Moerman A., Madic J., Rijsewijk F.A., Quak J., Gielkens A.L., van Oirschot J.T. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine 1994, 12(5):439-444.
36. Katoh K., Kuma K., Toh H., Miyata T. MAFFT version 5: improvement in accuracy of multiple sequence alignment. Nucleic Acids Res. 2005, 33(2):511-518.
37. Kawabata A., Jasirwan C., Yamanishi K., Mori Y. Human herpesvirus 6 glycoprotein M is essential for virus growth and requires glycoprotein N for its maturation. Virology 2012, 429(1):21-28.
38. Keeler C.L., Hazel J.W., Hastings J.E., Rosenberger J.K. Restriction endonuclease analysis of Delmarva field isolates of infectious laryngotracheitis virus. Avian Dis. 1993, 37(2):418-426.
39. Keller L.H., Benson C.E., Davison S., Eckroade R.J. Differences among restriction endonuclease DNA fingerprints of Pennsylvania field isolates, vaccine strains, and challenge strains of infectious laryngotracheitis virus. Avian Dis. 1992, 36(3):575-581.
40. Kirkpatrick N.C., Mahmoudian A., O'Rourke D., Noormohammadia A.H. Differentiation of infectious laryngotacheitis vius isolates by restriction fragment length polymorphis analysis of polymerase chain reaction products amplified from multiple genes. Avian Dis 2006, 50:28-34.
41. Konig P., Giesow K., Keil G.M. Glycoprotein M of bovine herpesvirus 1 (BHV-1) is nonessential for replication in cell culture and is involved in inhibition of bovine respiratory syncytial virus F protein induced syncytium formation in recombinant BHV-1 infected cells. Vet. Microbiol. 2002, 86(1-2):37-49.
42. Kumar S., Tamura K., Nei M. MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 2004, 5(2):150-163.
43. Lee S.W., Devlin J.M., Markham J.F., Noormohammadi A.H., Browning G.F., Ficorilli N.P., Hartley C.A., Markham P.F. Comparative analysis of the complete genome sequences of two Australian origin live attenuated vaccines of infectious laryngotracheitis virus. Vaccine 2011, 29(52):9583-9587.
44. Lee S.W., Markham P.F., Coppo M.J., Legione A.R., Markham J.F., Noormohammadi A.H., Browning G.F., Ficorilli N., Hartley C.A., Devlin J.M. Attenuated vaccines can recombine to form virulent field viruses. Science 2012, 337(6091):188.
45. Lee S.W., Markham P.F., Markham J.F., Petermann I., Noormohammadi A.H., Browning G.F., Ficorilli N.P., Hartley C.A., Devlin J.M. First complete genome sequence of infectious laryngotracheitis virus. BMC Genomics 2011, 12:197.
46. Liu H.C., Niikura M., Fulton J.E., Cheng H.H. Identification of chicken lymphocyte antigen 6 complex, locus E (LY6E, alias SCA2) as a putative Marek's disease resistance gene via a virus-host protein interaction screen. Cytogenet. Genome. Res. 2003, 102(1-4):304-308.
47. Lole K.S., Bollinger R.C., Paranjape R.S., Gadkari D., Kulkarni S.S., Novak N.G., Ingersoll R., Sheppard H.W., Ray S.C. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol. 1999, 73(1):152-160.
48. Lomniczi B., Blankenship M.L., Ben-Porat T. Deletions in the genomes of pseudorabies virus vaccine strains and existence of four isomers of the genomes. J Virol. 1984, 49(3):970-979.
49. Margulies M., Egholm M., Altman W.E., Attiya S., Bader J.S., Bemben L.A., Berka J., Braverman M.S., Chen Y.J., Chen Z., Dewell S.B., Du L., Fierro J.M., Gomes X.V., Godwin B.C., He W., Helgesen S., Ho C.H., Irzyk G.P., Jando S.C., Alenquer M.L., Jarvie T.P., Jirage K.B., Kim J.B., Knight J.R., Lanza J.R., Leamon J.H., Lefkowitz S.M., Lei M., Li J., Lohman K.L., Lu H., Makhijani V.B., McDade K.E., McKenna M.P., Myers E.W., Nickerson E., Nobile J.R., Plant R., Puc B.P., Ronan M.T., Roth G.T., Sarkis G.J., Simons J.F., Simpson J.W., Srinivasan M., Tartaro K.R., Tomasz A., Vogt K.A., Volkmer G.A., Wang S.H., Wang Y., Weiner M.P., Yu P., Begley R.F., Rothberg J.M. Genome sequencing in microfabricated high-density picolitre reactors. Nature 2005, 437(7057):376-380.
50. May H.G., Tittsler R.P. Tracheolaryngitis in poultry. J. Am.Vet. Med. Assoc. 1925, 67:229-231.
51. May J.S., Colaco S., Stevenson P.G. Glycoprotein M is an essential lytic replication protein of the murine gammaherpesvirus 68. J. Virol. 2005, 79(6):3459-3467.
52. Mettenleiter T.C., Lukacs N., Rziha H.J. Pseudorabies virus avirulent strains fail to express a major glycoprotein. J. Virol. 1985, 56(1):307-311.
53. Mundt A., Mundt E., Hogan R.J., Garcia M. Glycoprotein J of infectious laryngotracheitis virus is required for efficient egress of infectious virions from cells. J. Gen. Virol. 2011, 92(Pt 11):2586-2589.
54. Neff C.J., Sudler C., Hoop R.K. Characterisation of western European field isolates of avian infectious laryngotracheitis virus by restriction fragment length polymorphisms and sequencing. Avian Dis. 2008, 52:278-283.
55. Ojkic D., Swinton J., Vallieres M., Martin E., Shapiro J., Sanei B., Binnington B. Characterization of field isolates of infectious laryngotracheitis virus from Ontario. Avian Pathol. 2006, 35(4):286-292.
56. Oldoni I., Garcia M. Characterization of infectious laryngotracheitis virus isolates from the US by polymerase chain reaction and restriction fragment length polymorphism of multiple genome regions. Avian Pathol. 2007, 36(2):167-176.
57. Oldoni I., Rodriguez-Avila A., Riblet S., Garcia M. Characterization of infectious laryngotracheitis virus (ILTV) isolates from commercial poultry by polymerase chain reaction and restriction fragment length polymorphisms (PCR-RFLP). Avian Dis. 2008, 52:59-63.
58. Oldoni I., Rodriguez-Avila A., Riblet S.M., Zavala G., García M. Pathogenicity and Growth Characteristics of Infectious Laryngotracheitis Virus (ILTV) Isolates from United States. Avian Pathology 2009, 38:47-53.
59. Rodríguez-Avila A., Oldoni I., Riblet S., García.M. Replication and transmission of live-attenuated Infectiouslaryngotracheitis virus (ILTV) vaccines. Avian Dis. 2007, 51:905-911.
60. Rodríguez-Avila A., Oldoni I., Riblet S.M., García M. Evaluation of the Protection Elicited by Direct and Indirect Exposure to Live Attenuated Infectious Laryngotracheitis Virus (ILTV) Vaccines Against a Recent Challenge Strain from the United States. Avian Pathology 2008, 37:287-292.
61. Ross L.J., Sanderson M., Scott S.D., Binns M.M., Doel T., Milne B. Nucleotide sequence and characterization of the Marek's disease virus homologue of glycoprotein B of herpes simplex virus. J. Gen. Virol. 1989, 70(Pt 7):1789-1804.
62. Sadeghi M., Bozorgemehrifard M.H., Keyvanfar H., Momtaz H., Shooshtari A., Charkhkar S. Differentiation of field isolates and vaccine strains of infectious laryngotracheitis virus by DNA sequencing. Afr. J. Microbiol. Res. 2011, 5:4112-4117.
63. Samberg Y., Aronovici I. The development of a vaccine against avian infectious laryngotracheitis. I. Modification of a laryngotracheitis virus. Refu. Vet 1969, 26:54-59.
64. Schumacher D., Tischer B.K., Reddy S.M., Osterrieder N. Glycoproteins E and I of Marek's disease virus serotype 1 are essential for virus growth in cultured cells. J. Virol. 2001, 75(23):11307-11318.
65. Silva R.F., Witter R.L. Genomic expansion of Marek's disease virus DNA is associated with serial in vitro passage. J. Virol. 1985, 54(3):690-696.
66. Spatz S.J., Volkening J.D., Keeler C.L., Kutish G.F., Riblet S.M., Boettger C.M., Clark K.F., Zsak L., Afonso C.L., Mundt E.S., Rock D.L., Garcia M. Comparative full genome analysis of four infectious laryngotracheitis virus (Gallid herpesvirus-1) virulent isolates from the United States. Virus Genes. 2012, 44(2):273-285.
67. Suzutani T., Nagamine M., Shibaki T., Ogasawara M., Yoshida I., Daikoku T., Nishiyama Y., Azuma M. The role of the UL41 gene of herpes simplex virus type 1 in evasion of non-specific host defence mechanisms during primary infection. J. Gen. Virol. 2000, 81(Pt 7):1763-1771.
68. Szpara M.L., Tafuri Y.R., Parsons L., Shamim S.R., Verstrepen K.J., Legendre M., Enquist L.W. A wide extent of inter-strain diversity in virulent and vaccine strains of alphaherpesviruses. PLoS Pathol. 2011, 7(10):e1002282.
69. Team, R.D.C. (2009). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. Vienna, Austria.
70. Thureen D.R., Keeler C.L. Psittacid herpesvirus 1 and infectious laryngotracheitis virus: comparative genome sequence analysis of two avian alphaherpesviruses. J. Virol. 2006, 80(16):7863-7872.
71. Tischer B.K., Schumacher D., Messerle M., Wagner M., Osterrieder N. The products of the UL10 (gM) and the UL49.5 genes of Marek's disease virus serotype 1 are essential for virus growth in cultured cells. J. Gen. Virol. 2002, 83(Pt 5):997-1003.
72. Tong G.Z., Zhang S.J., Wang L., Qiu H.J., Wang Y.F., Wang M. Protection of chickens from infectious laryngotracheitis with a recombinant fowlpox virus expressing glycoprotein B of infectious laryngotracheitis virus. Avian Pathol. 2001, 30(2):143-148.
73. Tripathy D.N., Garcia M. Laryngotracheitis. Isolation and Identification of Avian Pathogens 2008, 94-98. University of Pennsylvania, New Bolton Center, PA. 5th Ed. D.E. Swayne, J.R. Glisson, M.W. Jackwood, J.E. Pearson, W.M. Reed (Eds.).
74. Vagnozzi A., Zavala G., Riblet S.M., Mundt A., García M. Protection induced by Infectious laryngotracheits virus (ILTV) Live-attenuated and Recombinant Viral Vector Vaccines in Broilers. Avian Pathology 2012, 41:21-31.
75. van Engelenburg F.A., Kaashoek M.J., Rijsewijk F.A., van den Burg L., Moerman A., Gielkens A.L., van Oirschot J.T. A glycoprotein E deletion mutant of bovine herpesvirus 1 is avirulent in calves. J. Gen. Virol. 1994, 75(Pt 9):2311-2318.
76. Veits J., Mettenleiter T.C., Fuchs W. Five unique open reading frames of infectious laryngotracheitis virus are expressed during infection but are dispensable for virus replication in cell culture. J. Gen. Virol. 2003, 84(Pt 6):1415-1425.
77. Volkening J.D., Spatz S.J. Purification of DNA from the cell-associated herpesvirus Marek's disease virus for 454 pyrosequencing using micrococcal nuclease digestion and polyethylene glycol precipitation. J. Virol. Methods. 2009, 157(1):55-61.
78. Yang K., Baines J.D. The putative terminase subunit of herpes simplex virus 1 encoded by UL28 is necessary and sufficient to mediate interaction between pUL15 and pUL33. J. Virol. 2006, 80(12):5733-5739.
79. Yu D., Weller S.K. Herpes simplex virus type 1 cleavage and packaging proteins UL15 and UL28 are associated with B but not C capsids during packaging. J. Virol 1998, 72(9):7428-7439.
80. Zhang J., Nagel C.H., Sodeik B., Lippe R. Early, active, and specific localization of herpes simplex virus type 1 g to nuclear membranes. J. Virol. 2009, 83(24):12984-12997.